Ervin Woodle

Professor of Surgery, William A. Altemeier Endowed Chair in Surgery

University of Cincinnati College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Ervin Woodle holds the William A. Altemeier Endowed Chair in Surgery at the University of Cincinnati College of Medicine in the United States. His research areas include pharmacokinetics in transplantation, single-cell transcriptional analysis of transplant rejection, and optimization of immunosuppressive therapies. He has contributed significantly to the understanding of treatments and outcomes in pediatric kidney transplants and solid organ transplantation in patients with malignancies.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

David Allman

Professor

University of Pennsylvania

UNITED STATES

View details

James J. Driscoll

Case Western Reserve University

UNITED STATES

View details

David Hildeman

University of Cincinnati

UNITED STATES

View details

Rita Alloway

University of Cincinnati

UNITED STATES

View details

Alin Girnita

Professor

Stanford University School of Medicine

UNITED STATES

View details

Adele Shields

Research Associate Professor, Clinical Transplant Pharmacist

University of Cincinnati

UNITED STATES

View details

Simon Tremblay

UNITED STATES

View details

Dixon Kaufman

Professor of Surgery

University of Wisconsin-Madison

UNITED STATES

View details

Ralph Quillin

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ervin Woodle

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT‐EXT Pharmacokinetic Analysis

Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells

Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations

The Proteasome Inhibitor Bortezomib Induces p53-Dependent Apoptosis in Activated B Cells.

Carfilzomib‐based antibody mediated rejection therapy in pediatric kidney transplant recipients

Belatacept for Simultaneous Calcineurin Inhibitor and Chronic Corticosteroid Immunosuppression Avoidance

Plasma cell biology: Foundations for targeted therapeutic development in transplantation

Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients

Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement

Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement

Plasma cell targeting to prevent antibody-mediated rejection

Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial

A prospective, iterative, adaptive trial of carfilzomib-based desensitization

Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy

Collaborators (9)

David Allman

James J. Driscoll

David Hildeman

Rita Alloway

Alin Girnita

Adele Shields

Simon Tremblay

Dixon Kaufman

Ralph Quillin

Make your next move.